Dexcom builds on its history of first-in-market innovations with the launch of its new groundbreaking GenAI platform Dexcom GenAI-enabled technology will leverage Google Cloud’s Vertex AI platform and ...
The FDA has approved Dexcom's G7 wearable for glucose monitoring for people with all types of diabetes, and the company expects it hit pharmacy shelves in 2023. The wearable is now cleared in the US ...
It is estimated that approximately 400,000 people in the UK are living with type 1 diabetes, including around 29,000 children. In type 1 diabetes, a person's blood glucose level becomes too high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback